[Clinical application of clindamycin-2-phosphate to otorhinolaryngological infections (author's transl)].
D000208:Acute Disease; D000328:Adult; D000368:Aged; D002648:Child; D002981:Clindamycin / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D004341:Drug Evaluation; D005260:Female; D005402:Fistula / Q000188:drug therapy; D005667:Furunculosis / Q000188:drug therapy; D006801:Humans; D007223:Infant; D007273:Injections, Intramuscular; D008297:Male; D008875:Middle Aged; D010033:Otitis Media / Q000188:drug therapy; D010038:Otorhinolaryngologic Diseases / Q000188:drug therapy*; D010309:Parotitis / Q000188:drug therapy; D000039:Peritonsillar Abscess / Q000188:drug therapy; D014069:Tonsillitis / Q000188:drug therapy
D002981:Clindamycin